Search results
Here is What to Know Beyond Why AbbVie Inc. (ABBV) is a Trending Stock
Zacks via Yahoo News· 3 weeks agoAbbVie (ABBV) has recently been on Zacks.com's list of the most searched stocks. Therefore, you...
The Zacks Analyst Blog Highlights Novo Nordisk, AbbVie, AstraZeneca, Air T and United-Guardian
Zacks via Yahoo News· 3 weeks agoFor Immediate Release Chicago, IL – July 11, 2024 – Zacks.com announces the list of stocks featured...
Should First Trust Morningstar Dividend Leaders ETF (FDL) Be on Your Investing Radar?
Zacks via Yahoo News· 3 weeks agoLooking for broad exposure to the Large Cap Value segment of the US equity market? You should...
2 Boston Partners Mutual Funds for Maximum Returns
Zacks via Yahoo News· 4 weeks agoEstablished in 1995 Boston Partners is an investment company managing $103 billion in assets. Specializing in value equity and long/short equity...
Company News for Jul 3, 2024
Zacks via Yahoo News· 1 month agoShares of Tesla, Inc. TSLA soared 10.2% on reporting a lower-than-expected drop in vehicle deliveries for second-quarter 2024. Shares of Apple Inc. AAPL...
AbbVie's (ABBV) Celsius Therapeutics Deal to Boost IBD Presence
Zacks via Yahoo News· 1 month agoAbbVie's (ABBV) acquisition of Celsius Therapeutics is set to add the latter's lead pipeline...
Is Invesco Pharmaceuticals ETF (PJP) a Strong ETF Right Now?
Zacks via Yahoo News· 1 month agoDesigned to provide broad exposure to the Health Care ETFs category of the market, the Invesco...
FDA Expands AbbVie's (ABBV) Epkinly Label in Follicular Lymphoma
Zacks via Yahoo News· 1 month agoFollowing the label expansion, AbbVie's (ABBV) Epkinly is the first bispecific antibody approved to...
Merck's (MRK) Lung Cancer Candidate Faces FDA Rejection
Zacks via Yahoo News· 1 month agoThe FDA's CRL to Merck (MRK) and its partner Daiichi Sankyo for the patritumab deruxtecan BLA is...
3 Healthcare Mutual Funds Thriving Amid Economic Shifts
Zacks via Yahoo News· 1 month agoHealthcare mutual funds such as FPHAX, VGHCX and PHSTX are increasingly favored as solid investments...